banner investors


You can leave a message.
We will contact you as soon as possible
Please type your full name.

Invalid email address.

Invalid Input

Invalid Input


Latest news

showCyTuVax has shown the strength of its vaccine adjuvant technology in the Phase 2 clinical trial of a vaccine for hepatitis B non-responders
Press release 17-06-2019

Where we are

About us

CyTuVax B.V.
Oxfordlaan 55
6229 EV Maastricht
The Netherlands

Contact us by email